US Patent Issued to Neurotech USA on July 15 for "Use of encapsulated cell therapy for treatment of ophthalmic disorders" (California, Rhode Island, Massachusetts Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,566, issued on July 15, was assigned to Neurotech USA Inc. (Cumberland, R.I.).

"Use of encapsulated cell therapy for treatment of ophthalmic disorders" was invented by Jeffrey Louis Goldberg (San Diego), Cahil McGovern (North Kingstown, R.I.), Weng Tao (Lincoln, R.I.) and Konrad A Kauper (Sutton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retiniti...